Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05889988 |
|---|---|
| Brief Title: | A Study of Ado-trastuzumab Emtansine (T-DM1)-Induced Peripheral Neuropathy in HER2-positive Breast Cancer Patients |
| First Submitted : | May 25, 2023 |
| First Submitted that Met QC Criteria : | May 25, 2023 |
| First Posted : | June 5, 2023 |
| Last Update Submitted that Met QC Criteria : | January 4, 2024 |
| Last Update Posted : | January 8, 2024 |